D.A. Davidson & Co’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $980K | Buy |
20,337
+8,847
| +77% | +$412K | 0.01% | 940 |
|
|
2025
Q4 | $557K | Buy |
11,490
+6,306
| +122% | +$313K | ﹤0.01% | 1103 |
|
|
2025
Q3 | $245K | Buy |
5,184
+277
| +6% | +$13.4K | ﹤0.01% | 1371 |
|
|
2025
Q2 | $237K | Sell |
4,907
-2,003
| -29% | -$102K | ﹤0.01% | 1299 |
|
|
2025
Q1 | $383K | Buy |
6,910
+8
| +0.1% | +$433 | ﹤0.01% | 1129 |
|
|
2024
Q4 | $333K | Sell |
6,902
-3,921
| -36% | -$199K | ﹤0.01% | 1170 |
|
|
2024
Q3 | $624K | Sell |
10,823
-327
| -3% | -$17.7K | 0.01% | 930 |
|
|
2024
Q2 | $540K | Buy |
11,150
+3,597
| +48% | +$174K | ﹤0.01% | 945 |
|
|
2024
Q1 | $367K | Sell |
7,553
-392
| -5% | -$19.1K | ﹤0.01% | 1101 |
|
|
2023
Q4 | $395K | Sell |
7,945
-440
| -5% | -$21.5K | ﹤0.01% | 1031 |
|
|
2023
Q3 | $450K | Sell |
8,385
-5,462
| -39% | -$291K | ﹤0.01% | 948 |
|
|
2023
Q2 | $746K | Sell |
13,847
-955
| -6% | -$51.4K | 0.01% | 788 |
|
|
2023
Q1 | $806K | Sell |
14,802
-1,626
| -10% | -$79.1K | 0.01% | 750 |
|
|
2022
Q4 | $796K | Buy |
16,428
+6,424
| +64% | +$282K | 0.01% | 699 |
|
|
2022
Q3 | $380K | Buy |
10,004
+4,161
| +71% | +$185K | 0.01% | 912 |
|
|
2022
Q2 | $292K | Buy |
5,843
+625
| +12% | +$33.2K | ﹤0.01% | 1025 |
|
|
2022
Q1 | $268K | Buy |
5,218
+100
| +2% | +$5.16K | ﹤0.01% | 1116 |
|
|
2021
Q4 | $256K | Sell |
5,118
-150
| -3% | -$7.42K | ﹤0.01% | 1102 |
|
|
2021
Q3 | $254K | Buy |
5,268
+150
| +3% | +$7.63K | ﹤0.01% | 1079 |
|
|
2021
Q2 | $270K | Sell |
5,118
-110
| -2% | -$5.74K | ﹤0.01% | 1033 |
|
|
2021
Q1 | $259K | Sell |
5,228
-200
| -4% | -$9.61K | ﹤0.01% | 1005 |
|
|
2020
Q4 | $264K | Sell |
5,428
-300
| -5% | -$14.8K | ﹤0.01% | 889 |
|
|
2020
Q3 | $287K | Buy |
5,728
+241
| +4% | +$12.4K | 0.01% | 784 |
|
|
2020
Q2 | $280K | Buy |
5,487
+391
| +8% | +$19K | 0.01% | 766 |
|
|
2020
Q1 | $223K | Sell |
5,096
-351
| -6% | -$16.8K | ﹤0.01% | 840 |
|
|
2019
Q4 | $273K | Buy |
5,447
+579
| +12% | +$27.1K | ﹤0.01% | 861 |
|
|
2019
Q3 | $226K | Buy |
+4,868
| New | +$210K | ﹤0.01% | 885 |
|
|
2018
Q4 | – | Sell |
-4,553
| Closed | -$203K | – | 1159 |
|
|
2018
Q3 | $203K | Sell |
4,553
-2,249
| -33% | -$96.1K | ﹤0.01% | 1072 |
|
|
2018
Q2 | $272K | Buy |
6,802
+231
| +4% | +$9.09K | 0.01% | 914 |
|
|
2018
Q1 | $263K | Buy |
6,571
+606
| +10% | +$25.2K | 0.01% | 894 |
|
|
2017
Q4 | $257K | Buy |
5,965
+1,017
| +21% | +$46.9K | 0.01% | 910 |
|
|
2017
Q3 | $246K | Sell |
4,948
-411
| -8% | -$19.9K | ﹤0.01% | 927 |
|
|
2017
Q2 | $256K | Sell |
5,359
-1,102
| -17% | -$52.7K | 0.01% | 855 |
|
|
2017
Q1 | $292K | Sell |
6,461
-87
| -1% | -$3.69K | 0.01% | 793 |
|
|
2016
Q4 | $263K | Sell |
6,548
-171
| -3% | -$6.74K | 0.01% | 883 |
|
|
2016
Q3 | $254K | Buy |
6,719
+1,231
| +22% | +$49.4K | 0.01% | 849 |
|
|
2016
Q2 | $227K | Buy |
5,488
+562
| +11% | +$23K | 0.01% | 802 |
|
|
2016
Q1 | $196K | Sell |
4,926
-736
| -13% | -$29.6K | 0.01% | 844 |
|
|
2015
Q4 | $239K | Sell |
5,662
-872
| -13% | -$40.1K | 0.01% | 784 |
|
|
2015
Q3 | $309K | Sell |
6,534
-603
| -8% | -$30.7K | 0.01% | 671 |
|
|
2015
Q2 | $351K | Sell |
7,137
-1,053
| -13% | -$53.4K | 0.01% | 673 |
|
|
2015
Q1 | $403K | Buy |
8,190
+592
| +8% | +$28.3K | 0.01% | 633 |
|
|
2014
Q4 | $344K | Sell |
7,598
-7,807
| -51% | -$379K | 0.01% | 688 |
|
|
2014
Q3 | $867K | Buy |
15,405
+328
| +2% | +$17.6K | 0.03% | 448 |
|
|
2014
Q2 | $799K | Sell |
15,077
-699
| -4% | -$37.1K | 0.03% | 477 |
|
|
2014
Q1 | $822K | Buy |
15,776
+2,082
| +15% | +$105K | 0.03% | 465 |
|
|
2013
Q4 | $731K | Buy |
13,694
+9,614
| +236% | +$496K | 0.03% | 483 |
|
|
2013
Q3 | $204K | Sell |
4,080
-5
| -0.1% | -$254 | 0.01% | 694 |
|
|
2013
Q2 | $208K | Buy |
+4,085
| New | +$218K | 0.01% | 662 |
|
Other funds holding SNY
MIP
D.A. Davidson & Co's SNY Position: Q1 2026 in Review
D.A. Davidson & Co increased its Sanofi (SNY) stake by 77% in Q1 2026, buying an estimated $412K and bringing the position to 20,337 shares worth $980K. The position accounts for 0.01% of the portfolio, ranked #940.
D.A. Davidson & Co first reported a position in SNY in Q2 2013 and has held it in 49 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- D.A. Davidson & Co held 20,337 shares of Sanofi worth $980K as of Q1 2026.
- D.A. Davidson & Co bought 8,847 Sanofi shares in Q1 2026, an estimated $412K.
- Sanofi made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #940 holding.
- D.A. Davidson & Co first reported a position in Sanofi in Q2 2013 and has held it in 49 quarters since.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.